about
B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib.Characterization and significance of the Philadelphia negative/BCR-ABL1 positive rearrangement or masked Philadelphia translocation in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single-center study
P50
description
researcher (ORCID 0000-0002-3347-956X)
@en
name
Blazej Ratajczak
@en
type
label
Blazej Ratajczak
@en
prefLabel
Blazej Ratajczak
@en
P31
P496
0000-0002-3347-956X